Repeated low-level red-light therapy
Eyerising International responds to China myopia red light regulatory changes
Repeated low-level red-light (RLRL) device manufacturer Eyerising International says the reclassification of the emerging myopia management intervention in China is...
Read moreDetails
Eyerising International refutes ‘inaccurate claims’ in University of Houston red light myopia study
Australian medical device company Eyerising International says its device has been “misrepresented” in a recent study over the safety...
Read moreDetails
Rare complication case: Eyerising International addresses safety questions
Eyerising International has addressed questions over the safety of its repeated-low level red-Light (RLRL) treatment for myopia management, following two...
Read moreDetails